Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22muscular+dystrophy%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
/vufind/Search/Results?lookfor=%22muscular+dystrophy%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
Search /vufind/Search2/Results?lookfor=%22muscular+dystrophy%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
PubPharm (428)
1
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) : A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study : A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON) : A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of a High Dose of Eteplirsen, Preceded by an Open-label Dose Escalation, in Patients With Duchenne Muscular Dystrophy With Deletion Mutations Amenable to Exon 51 Skipping
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy : A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF 06939926 FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy : A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy : A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) : A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) : A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP- 9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) : A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) : A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled, 48-Week, Parallel-Group Study of the Efficacy and Safety of Losmapimod in Treating Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
428
Aufsätze
428
E-Artikel
428
E-Ressourcen
Zeitschriftentitel
374
WHO International Clinical Trials Registry Plat...
54
ClinicalTrials.gov
Thema
428
610
Phase: Phase 3
428
Study Type: Interventional
186
Recruitment Status: Not yet recruiting
138
Recruitment Status: Authorised-recruitment may ...
80
Medical Condition: Duchenne Muscular Dystrophy ...
54
Muscular Dystrophies
46
Muscular Dystrophy, Duchenne
36
Medical Condition: Duchenne Muscular Dystrophy ...
26
Medical Condition: Patients with Duchenne Muscu...
25
Recruitment Status: Recruiting
20
Recruitment Status: Completed
14
Medical Condition: Patients with Duchenne Muscu...
13
Recruitment Status: Terminated
12
Medical Condition: Duchenne Muscular Dystrophy ...
12
Medical Condition: Non-ambulatory Duchenne Musc...
12
Medical Condition: Nonsense mutation dystrophin...
10
Medical Condition: DUCHENNE MUSCULAR DYSTROPHY ...
10
Medical Condition: Duchenne muscular dystrophy ...
9
Recruitment Status: Active, not recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
309
2020-
119
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
422
Englisch
4
Französisch
2
Italienisch
Haven't found what you're looking for?
Wird geladen...